All Relations between Dementia and dlb

Publication Sentence Publish Date Extraction Date Species
H Ohtake, P Limprasert, Y Fan, O Onodera, A Kakita, H Takahashi, L T Bonner, D W Tsuang, I V J Murray, V M-Y Lee, J Q Trojanowski, A Ishikawa, J Idezuka, M Murata, T Toda, T D Bird, J B Leverenz, S Tsuji, A R La Spad. Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology. vol 63. issue 5. 2005-04-08. PMID:15365127. to determine whether mutations in the genes for alpha-synuclein or beta-synuclein are responsible for dementia with lewy bodies (dlb), a disorder closely related to parkinson disease (pd). 2005-04-08 2023-08-12 Not clear
Marwan N Sabbagh, Nina B Silverberg, Douglas Walker, Donald J Connor, James D Seward, Ida P Crocker-Sabbagh, Rochelle L Descheny, Minnie Jim, Leslie C Baxte. Case series of clinically probable dementia with Lewy bodies in two Native Americans. Alzheimer disease and associated disorders. vol 18. issue 4. 2005-04-05. PMID:15592141. here, we report 2 cases of clinically probable dementia with lewy bodies (dlb) that fulfill mckeith consensus criteria in an 84-year-old full-blooded navajo woman and a 78-year-old full-blooded navajo male assessed in a neurology clinic. 2005-04-05 2023-08-12 Not clear
Sid Gilman, Robert A Koeppe, Roderick Little, Hyonggin An, Larry Junck, Bruno Giordani, Carol Persad, Mary Heumann, Kris Wernett. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Experimental neurology. vol 191 Suppl 1. 2005-03-29. PMID:15629765. we compared the relative utility of neuropsychological testing and positron emission tomography (pet) with [18f]fluorodeoxyglucose ([18f]fdg) in differentiating alzheimer's disease (ad) from dementia with lewy bodies (dlb). 2005-03-29 2023-08-12 Not clear
Jack van Horssen, Rob A I de Vos, Ernst N H Jansen Steur, Guido David, Pieter Wesseling, Robert M W de Waal, Marcel M Verbee. Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains. Journal of Alzheimer's disease : JAD. vol 6. issue 5. 2005-03-21. PMID:15505367. alpha-synuclein is the major constituent of lewy bodies and lewy neurites in parkinson's disease (pd) and dementia with lewy bodies (dlb). 2005-03-21 2023-08-12 Not clear
Marta Barrachina, Esther Dalfó, Berta Puig, Noemi Vidal, Meritxell Freixes, Esther Castaño, Isidro Ferre. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor. Neurochemistry international. vol 46. issue 3. 2005-03-16. PMID:15670642. deposition of amyloid-beta, the fibrillogenic product of the cell surface protein abetapp (amyloid-beta protein precursor), occurs in the cerebral cortex of patients with dementia with lewy bodies (dlb). 2005-03-16 2023-08-12 Not clear
M Doran, A J Larne. EEG findings in dementia with Lewy bodies causing diagnostic confusion with sporadic Creutzfeldt-Jakob disease. European journal of neurology. vol 11. issue 12. 2005-03-14. PMID:15667416. two patients with pathologically confirmed dementia with lewy bodies (dlb) had electroencephalogram recordings reported to show periodic discharges suggestive or typical of creutzfeldt-jakob disease. 2005-03-14 2023-08-12 Not clear
Junichi Taki, Mitsuhiro Yoshita, Masahito Yamada, Norihisa Tonam. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Annals of nuclear medicine. vol 18. issue 6. 2005-03-08. PMID:15515743. dementia with lewy bodies (dlb) also shows severe reduction of mibg uptake, whereas alzheimer's disease (ad) demonstrates normal mibg uptake, permitting differentiation of dlb from ad using mibg scintigraphy. 2005-03-08 2023-08-12 Not clear
Shigeo Murayama, Yuko Saito, Kenji Ishii, Kazuko Mitani, Kazutomi Kanemaru, Hiroshi Yamanouchi, Hiroshi Kurisaki, Ichiro Imafuk. [Parkinson disease with dementia--responsible locus for dementia]. Rinsho shinkeigaku = Clinical neurology. vol 44. issue 11. 2005-03-04. PMID:15651303. following the one-year rule by the first consensus guidelines, definite ad pathology was quite rare in pd with dementia (pdd) but common in dementia with lewy bodies (dlb) . 2005-03-04 2023-08-12 Not clear
I J Bohr, M A Ray, J M McIntosh, S Chalon, D Guilloteau, I G McKeith, R H Perry, F Clementi, E K Perry, J A Court, M A Piggot. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus. Experimental neurology. vol 191. issue 2. 2005-02-18. PMID:15649484. in the present study, we have compared the distribution of [(125)i]alpha-conotoxinmii binding in post mortem human tissue from four groups of patients: individuals with dementia with lewy bodies displaying extra-pyramidal features (dlb + epf), dlb without extra-pyramidal features (dlb - epf) parkinson's disease without dementia (pd) and age-matched controls. 2005-02-18 2023-08-12 human
Kazunari Ishii, Kayo Hosaka, Tetsuya Mori, Etsuro Mor. Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies. Annals of nuclear medicine. vol 18. issue 5. 2005-02-17. PMID:15462408. to investigate regional differences in cerebral glucose metabolism and blood flow of dementia with lewy bodies (dlb), we studied 7 subjects with dlb and 20 normal controls using f-18 fluorodeoxyglucose (fdg) and positron emission tomography (pet) and then examined the same 7 subjects and 20 other normal controls with i-123 iodoamphetamine (imp) and single photon emission computed tomography (spect). 2005-02-17 2023-08-12 human
Antony J Harding, Anurina Das, Jillian J Kril, William S Brooks, David Duffy, Glenda M Hallida. Identification of families with cortical Lewy body disease. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 128B. issue 1. 2005-02-16. PMID:15211643. until recently, cortical lewy body disease (clb) was considered essentially the same as dementia with lewy bodies (dlb). 2005-02-16 2023-08-12 Not clear
Satoshi Ukai, Masakiyo Yamamoto, Michio Tanaka, Masatoshi Taked. Treatment of typical Charles Bonnet syndrome with donepezil. International clinical psychopharmacology. vol 19. issue 6. 2005-02-15. PMID:15486523. although visual hallucinations in the elderly are often associated with dementia with lewy body (dlb), alzheimer's disease and delirium, they are excluded from the diagnosis of typical cbs, as are cognitive or psychiatric disturbances, sleep disorders and focal neurological lesions. 2005-02-15 2023-08-12 Not clear
Robert A Sweet, Ronald L Hamilton, Meryl A Butters, Benoit H Mulsant, Bruce G Pollock, David A Lewis, Oscar L Lopez, Steven T DeKosky, Charles F Reynold. Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15354182. cerebrovascular disease, alzheimer's disease (ad), and dementia with lewy bodies (dlb) have all been hypothesized to contribute to this increased risk, though prospective studies have yet to examine these hypotheses with autopsy confirmation of the clinical diagnoses. 2005-02-14 2023-08-12 human
Robert A Sweet, Ronald L Hamilton, Meryl A Butters, Benoit H Mulsant, Bruce G Pollock, David A Lewis, Oscar L Lopez, Steven T DeKosky, Charles F Reynold. Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15354182. cerebrovascular disease and dlb pathology were also frequent in the llmd subjects with dementia, and were found in an llmd subject without dementia. 2005-02-14 2023-08-12 human
Omar M A El-Agnaf, Katerina E Paleologou, Brett Greer, Abdulmawala M Abogrein, Jenny E King, Sultan A Salem, Nigel J Fullwood, Fiona E Benson, Rebecca Hewitt, Kirstie J Ford, Francis L Martin, Patrick Harriott, Mark R Cookson, David Allso. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 18. issue 11. 2005-02-08. PMID:15180968. convergent biochemical and genetic evidence suggests that the formation of alpha-synuclein (alpha-syn) protein deposits is an important and, probably, seminal step in the development of parkinson's disease (pd), dementia with lewy bodies (dlb) and multiple system atrophy (msa). 2005-02-08 2023-08-12 human
M-P Perriol, K Dujardin, P Derambure, A Marcq, J-L Bourriez, E Laureau, F Pasquier, L Defebvre, A Desté. Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. vol 76. issue 1. 2005-02-08. PMID:15608006. the disruption of ppi has never been studied in individuals suffering from dementia with lewy bodies (dlb). 2005-02-08 2023-08-12 Not clear
M-P Perriol, K Dujardin, P Derambure, A Marcq, J-L Bourriez, E Laureau, F Pasquier, L Defebvre, A Desté. Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. vol 76. issue 1. 2005-02-08. PMID:15608006. as attention deficits largely contribute to cognitive impairment in dlb, an investigation with a ppi paradigm is useful for differential diagnosis of dlb versus alzheimer's disease (ad) and parkinson's disease dementia (pdd). 2005-02-08 2023-08-12 Not clear
Carol F Lipp. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies. American journal of Alzheimer's disease and other dementias. vol 19. issue 6. 2005-02-08. PMID:15633942. we determined immunoreactivity for the synaptic-terminal specific protein synaptophysin in the outer molecular layer of the hippocampal dentate gyrus (omdg) in eight pid, nine ad, nine dementia with lewy bodies (dlb), and seven control cases. 2005-02-08 2023-08-12 Not clear
M Hashimoto, E Rockenstein, M Mante, L Crews, P Bar-On, F H Gage, R Marr, E Maslia. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene therapy. vol 11. issue 23. 2005-02-03. PMID:15483670. current experimental gene therapy approaches for parkinson's disease (pd) and dementia with lewy bodies (dlb) include the use of viral vectors expressing antiapoptosis genes, neurotrophic factors and dopaminergic system enzymes. 2005-02-03 2023-08-12 mouse
Petra Steinacker, Brit Mollenhauer, Mirko Bibl, Lukas Cepek, Hermann Esselmann, Peter Brechlin, Piotr Lewczuk, Sigrid Poser, Hans A Kretzschmar, Jens Wiltfang, Claudia Trenkwalder, Markus Ott. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases. Neuroscience letters. vol 370. issue 1. 2005-01-31. PMID:15489013. therefore we measured h-fabp in cerebrospinal fluid (csf) and serum of patients having cjd, dementia with lewy-bodies (dlb), alzheimer's disease (ad) and in non-demented control (ndc) patients. 2005-01-31 2023-08-12 Not clear